Prevalence of HPV-associated Eye Infection and Cytokine Levels in Tears From Patients Diagnosed With Pterygium
NCT ID: NCT04117386
Last Updated: 2020-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
141 participants
OBSERVATIONAL
2020-01-01
2020-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Treatment for HPV16+ ASC-US or LSIL
NCT03913117
Investigation Into the Infectivity Levels of Human Papilloma Virus (HPV) in Tonsillar Tissue
NCT02841631
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
NCT00788164
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
NCT05026138
Human Papillomatosis Genotyping of Children in Thailand
NCT01304966
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
\- The prevalence of HPV infection in primary pterygium is difference with prevalence in recurrent pterygium patients.
Secondary hypothesis
* Ocular HPV infection has association with HPV genitalia infection.
* Tears cytokine and growth factor level (IL-6, IL-18 and VEGF) are higher in pterygium HPV infection than non-HPV infection and also more than normal population
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Primary pterygium group
Participants who was diagnosed with primary pterygium
HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong)
HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong) for swab sample collected from pterygium and normal conjunctiva and also for urine collected in Colli-PeeTM device (Novosanis, Belgium)
Bio-Plex® 200 system (Bio- Rad, Hercules, CA)
Bioplex was use for measure cytokine IL-6, IL-18 and VEGF from tears collected from Schirmer strip
Secondary pterygium group
Participants who was diagnosed with secondary pterygium
HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong)
HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong) for swab sample collected from pterygium and normal conjunctiva and also for urine collected in Colli-PeeTM device (Novosanis, Belgium)
Bio-Plex® 200 system (Bio- Rad, Hercules, CA)
Bioplex was use for measure cytokine IL-6, IL-18 and VEGF from tears collected from Schirmer strip
Healthy participants as control group
Participants who have no pterygium and other inflammation disease in eyes
HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong)
HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong) for swab sample collected from pterygium and normal conjunctiva and also for urine collected in Colli-PeeTM device (Novosanis, Belgium)
Bio-Plex® 200 system (Bio- Rad, Hercules, CA)
Bioplex was use for measure cytokine IL-6, IL-18 and VEGF from tears collected from Schirmer strip
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong)
HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong) for swab sample collected from pterygium and normal conjunctiva and also for urine collected in Colli-PeeTM device (Novosanis, Belgium)
Bio-Plex® 200 system (Bio- Rad, Hercules, CA)
Bioplex was use for measure cytokine IL-6, IL-18 and VEGF from tears collected from Schirmer strip
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* presence of pterygium invading the cornea
Exclusion Criteria
* Presence of any ocular inflammation diseases
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chulalongkorn University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ngamjit Kasetsuwan
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ngamjit Kasetsuwan
Role: PRINCIPAL_INVESTIGATOR
Department of Ophthalmology, Chulalongkorn University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of medicine, Chulalongkorn university
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB NO. 405/62
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.